Biopharmaceuticals are medical drugs which are produced with the help of biotechnology. The US is the largest market for biopharmaceuticals and is the leader in terms of revenue, by a substantial margin. The biopharmaceutical market can be classified based on the class of the medical drug into recombinant proteins, monoclonal antibodies and purified proteins. Based on the therapeutic applications, biopharmaceuticals can be classified as blood factors, thrombolytic agents, hormones, hematopoietic growth factors, interferon’s and vaccines.  The US biopharmaceutical market was valued at USD 90 billion and is estimated to grow with a CAGR of 11%. Th...

The biopharmaceutical industry is focusing on the growing complexity of licensing deals in order to secure marketing and commercialization rights within partnership deals. The major challenge faced by the biopharmaceutical licensing market is asymmetry between licensor and licensees. The biopharmaceutical licensing industry is growing in popularity as large companies are becoming heavily dependent on alliances and licensing to gain access to newer technologies in the biopharmaceutical market.  This dependence has strengthened the bargaining position of smaller players as they are willing to expand their role beyond product discovery and development towards active participation in the biopharmaceutical products industry. 

Asklepios BioPharmaceutical, Inc. Product Pipeline Review 2012SummaryGlobal Market Directs pharmaceuticals report, Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2012 provides data on the Asklepios BioPharmaceutical, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Directs proprietary databases, Asklepios BioPharmaceutical, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Asklepios BioPharmaceutical, Inc. and industry-specific third party sources, put together by Global Markets Directs t...

Asklepios BioPharmaceutical, Inc. Product Pipeline Review 2012 Summary Global Market Directs pharmaceuticals report, Asklepios BioPharmaceutical, Inc. Product Pipeline Review 2012 provides data on the Asklepios BioPharmaceutical, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Asklepios BioPharmaceutical, Inc.s corporate website, SEC filings, investor presentations and featured p...

China's demand for biopharmaceuticals has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.

Downstream Processing in Biopharmaceuticals Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness GBI Research, the leading business intelligence provider, has released its latest research, Downstream Processing in Biopharmaceuticals Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness, which provides key data, information and analysis of the Contract Manufacturing Organization (CMO) industry, and the downstream processing and reagent market. The report provides comprehensive insight into the size of the CMO market, the downstream processing and reagent market and ...

SK Biopharmaceuticals Co., Ltd. Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, SK Biopharmaceuticals Co., Ltd. Product Pipeline Review 2012 provides data on the SK Biopharmaceuticals Co., Ltd.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, SK Biopharmaceuticals Co., Ltd.s corporate website, SEC filings, investor presentations and featured press releases, both from SK Biopharmaceuticals Co., Ltd. and industry-specific th...

Inspiration Biopharmaceuticals, Inc. Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, Inspiration Biopharmaceuticals, Inc. Product Pipeline Review 2012 provides data on the Inspiration Biopharmaceuticals, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Inspiration Biopharmaceuticals, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Inspiration Biopharmaceuticals, Inc....

Biopharmaceutical Manufacturing in India, China and South Korea Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth GBI Research, the leading business intelligence provider has released its latest research report, Biopharmaceutical Manufacturing in India, China and South Korea Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth. The report provides an analysis of biopharmaceuticals approved in 2010 and 2011, operating dynamics in the biopharmaceutical industry, the current scenario in biopharmaceutical manufacturing, key stakeholders, the current market size (2011) of biopharmaceuticals, and forecasts to 201...

Eiger BioPharmaceuticals, Inc. Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, Eiger BioPharmaceuticals, Inc. Product Pipeline Review 2012 provides data on the Eiger BioPharmaceuticals, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Eiger BioPharmaceuticals, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Eiger BioPharmaceuticals, Inc. and industry-specific third p...

RegeneRx Biopharmaceuticals, Inc. Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, RegeneRx Biopharmaceuticals, Inc. Product Pipeline Review 2012 provides data on the RegeneRx Biopharmaceuticals, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, RegeneRx Biopharmaceuticals, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from RegeneRx Biopharmaceuticals, Inc. and industry-s...

Accentia Biopharmaceuticals, Inc. Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, Accentia Biopharmaceuticals, Inc. Product Pipeline Review 2012 provides data on the Accentia Biopharmaceuticals, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Accentia Biopharmaceuticals, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Accentia Biopharmaceuticals, Inc. and industry-s...

Nabi Biopharmaceuticals Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, Nabi Biopharmaceuticals Product Pipeline Review 2012 provides data on the Nabi Biopharmaceuticalss research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Nabi Biopharmaceuticalss corporate website, SEC filings, investor presentations and featured press releases, both from Nabi Biopharmaceuticals and industry-specific third party sources, pu...

TechNavio's analysts forecast the Global Biopharmaceuticals market to grow at a CAGR of 4.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increased adoption of advanced technologies. The Global Biopharmaceuticals market has also been witnessing the trend of an increase in RandD activities. However, patent expiration of top-selling drugs could pose a challenge to the growth of this market. TechNavio's report, the Global Biopharmaceuticals Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; ...

This report is an in-depth financial evaluation of the GlobalBiopharmaceutical Companies. Using the unique Plimsoll method of analysis, each of the top 200 companies included is individually assessed and ranked against each other and compared to industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report: 85 of the 200 companies analysed have been rated as Danger 52 companies are ripe for takeover 123 companies achieved greater than 10% increase in sales last year. 78 companies made a pre-tax loss. 61 companies saw sales fall las...

GBI Research, the leading business intelligence provider, has released its latest research, Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries, which provides insights into global technology transfer strategies landscape. The report explores the recognized and increasing need for a better understanding between all stakeholders in the biopharmaceutical and pharmaceutical community concerning the efficient transfer of technologies created from early innovative research to the commercialization of new product technologies. The report introduces the concept of technology transfer and the organizational reasons for opting on technology transfer along with the major technologies transferred. It also ...

GBI Research's report, Upstream Processing in Biopharmaceuticals - Increasing Use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market, provides the key to market data on overall upstream process, Contract Manufacturing Organization (CMO) market for upstream processing, and the cell culture and reagent market. Market. The report also analyzes the strengths, weaknesses, opportunities, and threats for the key players in the CMO and cell culture and regent market. The report also discusses the key market drivers and restraints for the upstream processing, outsourcing to CMO and cell culture and reagent market. The report is based on proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts to provide...

GBI Research's report, “Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies”, provides the key data and analyzes the major challenges and drivers for the downstream industry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the downstream processing of biopharmaceuticals. The report also discusses the key market drivers and barriers for the growth of biomanufacturing in the pharmaceutical and biotech industry. The report is based on proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts to provide a comprehensive view of the Down Stream Processing in Biopharmace...

GBI Research, the leading business intelligence provider, has released its latest research, “Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotech Clusters, Funding Characteristics and Regulatory Landscape.” This pharmaceutical and healthcare report provides an overview of the small and medium biopharmaceutical enterprises in the North American and European regions. The report provides an insight in to the importance of Small and Medium Enterprises (SME) in the biotechnology industry. It covers market characterization, geographical spread of SMEs, drivers and restraints, regulatory scenarios and funding challenges faced by the biotechnology SME industry. The study reviews the role of SMEs in driving the pipeline within the biotechnol...